Navigation Links
23ème congrès européen sur l'Hypertension et la Protection Cardiovasculaire
Date:6/25/2013

233;té abordée dans l'étude SEVITENSION,[8] dont les premiers résultats ont été présentés lors d'une session de posters dans le cadre du congrès de l'ESH 2013.

L'étude SEVITENSION avait pour objectif de déterminer si l'association fixe olmésartan /amlodipine 40/10 mg pouvait réduire la pression artérielle centrale jusqu'à un niveau similaire à celui obtenu avec l'association du périndopril 8 mg et de l'amlodipine 10 mg, traitement utilisé dans l'étude CAFÉ. Les résultats montrent que non seulement cet objectif a été atteint, mais aussi que la réduction de la pression artérielle centrale était plus importante avec l'association fixe olmésartan /amlodipine 40/10 mg qu'avec l'association du périndopril 8 mg et de l'amlodipine 10 mg. Les autres mesures de la pression artérielle, brachiale conventionnelle ou en ambulatoire sur 24 heures, ont aussi confirmé la supériorité de l'association fixe olmésartan /amlodipine 40/10 mg. Par ailleurs, chez les trois quarts des patients (75,6%) traités avec l'association fixe olmésartan /amlodipine 40/10 mg, la pression artérielle était normalisée et donc inférieure au seuil recommandé par la Société Européenne d'Hypertension pour tous les patients hypertendus (PA<140/90 mmHg).[9] La proportion de patients ayant obtenu ce niveau de pression artérielle avec l'association du périndopril 8 mg et de l'amlodipine 10 mg était presque 20% plus faible (57,5%). "Depuis la publication de l'étude CAFÉ, la référence était l'association du périndopril 8 mg et de l'amlodipine 10 mg, c'est pourquoi nous avons comparé ce traitement de référence avec l'association fixe olm&
'/>"/>

SOURCE Daiichi Sankyo Europe GmbH
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
2. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
3. Global Leaders in Advanced Biofuels Industry Urge Congressional Leaders to Extend Critical Tax Provisions
4. Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
5. PharmAthene Presents Update on SparVax™ rPA Anthrax Vaccine Program at the 2012 World Vaccine Congress
6. Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London
7. ETEX Corporation to present at the 9th World Biomaterial Congress
8. Discovery Labs to Present AFECTAIR® Data at European Congress on Pediatric and Neonatal Ventilation
9. PROLOR Biotech Announces Presentation of Data on Its Long-Acting Clotting Factors at World Federation of Hemophilia World Congress
10. The Legends that Contributed to Silicon Valleys Eminence Assemble for Frost & Sullivans Growth, Innovation and Leadership 2012 Congress
11. BIOCOM Announces Endorsement in 52nd Congressional District Race
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/25/2015)... 25, 2015 truBrain , creator ... in this week,s Power Pitch segment of CNBC,s  ... the company,s traction and growth strategy, as well ... funding site CircleUp. The segment highlights ... validated by neurotechnology, while also discussing its decision ...
(Date:2/25/2015)... KONG, Feb. 25, 2015 China Cord Blood ... "Company"), China,s leading provider of cord blood collection, laboratory ... services, today announced its preliminary unaudited financial results for ... 2015 ended December 31, 2014. Third Quarter ... third quarter of fiscal 2015 increased by 10.7% to ...
(Date:2/25/2015)... Salt Lake City, Utah (PRWEB) February 25, 2015 ... was recently awarded a $604,000 grant from ... Science, Technology, Engineering, and Mathematics (STEM) program. , ... students demonstrating a financial need, enabling them to ... or bachelor’s degree in a STEM discipline. Institutions ...
(Date:2/25/2015)... NY (PRWEB) February 25, 2015 ... Reality” conference will take place on March ... Medicine in New York City. This single-day conference ... key investors, and other stakeholders to discuss in-depth ... field of cancer immunotherapy. The conference format is ...
Breaking Biology Technology:CNBC's Power Lunch Features Neurotechnology Start-up truBrain 2China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 2China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 3China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 4China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 5China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 6China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 7China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 8China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 9China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 10China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 11China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 12China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 13China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 14China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 15China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 16China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 17China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 18China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 19China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 20China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 21China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 22SLCC Receives $600K National Science Foundation Grant 25th Annual "Cancer Immunotherapy: A Long- Awaited Reality" Conference Taking Place March 26, 2015 in New York City 25th Annual "Cancer Immunotherapy: A Long- Awaited Reality" Conference Taking Place March 26, 2015 in New York City 3
... Ltd, a specialty,biopharmaceutical company focused on controlling ... successfully raised GBP11 million ($21.8,million) in an ... new investors Goldman Sachs and Invesco Perpetual, ... and Lansdowne,Partners., "Completing this financing is ...
... at Northwestern Universitys Center for Quantum Devices (CQD) ... detecting single photons in the ultraviolet region (360-200 ... only available technology in the short wavelength UV ... detection sensitivity. However, these fragile vacuum tube devices ...
... Researchers at Rensselaer Polytechnic Institute and Polyset Company ... could lead to dramatic cost savings and efficiency ... , Along with allowing enhanced performance and cost ... called polyset epoxy siloxane (PES), should also enable ...
Cached Biology Technology:Circassia Raises GBP11 Million ($21.8 Million) in Oversubscribed Second Round Funding 2Tiny avalanche photodiode detects single UV photons 2New polymer could improve semiconductor manufacturing, packaging 2
(Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: CPHD ... the following conferences, and invited investors to participate via webcast. ... Boston, MA Tuesday, March 3, 2015 at 11.20 ... Orlando, FL Wednesday, March 4, 2015 ... To access the live webcasts for these events, please visit ...
(Date:2/11/2015)... , February 11, 2015 ... research report "Access Control Market by Product (Cards and ... Residential, Military and Defense, Government, Industrial, Healthcare, Education) and ... published by MarketsandMarkets, the Access Control Market ... 2020, growing at a CAGR of 10.6% ...
(Date:2/5/2015)... 5, 2015  Marken is starting its 35 th ... launched a new marketing campaign to solidify its place ... new campaign focuses on First as a ... The first headline in the series, ... with its client,s priorities. Marken recognizes the need to ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... The same mechanism that stabilises the DNA in the ... function of vertebrate muscle cells. This has been established ... of Physiology) in cooperation with American and German colleagues. ... Hsp90, which then forms a complex with the muscle ...
... paddy fields in Japan with salty sludge, scientists are near ... collaboration, a new method for marker assisted breeding is being ... traits such as salt tolerance. Details of the new method, ... on Sunday so they can be used by scientists and ...
... work with engines traveling on straight tracks, a team ... Oxford have successfully used DNA building blocks to construct ... tracks with multiple switches. The findings, published in the ... Nanotechnology , are expected to lead to further developments ...
Cached Biology News:How protein networks stabilize muscle fibers: Same mechanism as for DNA 2Science to help rice growers affected by Japan's tsunami 2